Vaxart, Inc.
VXRT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $322,617 | $279,104 | $467,772 | $3,055,138 |
| - Cash | $25,229 | $34,755 | $44,013 | $143,745 |
| + Debt | $23,284 | $26,514 | $27,421 | $24,530 |
| Enterprise Value | $320,672 | $270,863 | $451,180 | $2,935,923 |
| Revenue | $28,700 | $7,379 | $107 | $892 |
| % Growth | 288.9% | 6,796.3% | -88% | – |
| Gross Profit | $28,700 | $2,879 | $107 | -$47,857 |
| % Margin | 100% | 39% | 100% | -5,365.1% |
| EBITDA | -$54,869 | -$72,133 | -$100,581 | -$66,451 |
| % Margin | -191.2% | -977.5% | -94,000.9% | -7,449.7% |
| Net Income | -$66,948 | -$82,465 | -$107,758 | -$70,470 |
| % Margin | -233.3% | -1,117.6% | -100,708.4% | -7,900.2% |
| EPS Diluted | -0.14 | -0.17 | -0.22 | -0.14 |
| % Growth | 17.6% | 22.7% | -57.1% | – |
| Operating Cash Flow | -$44,764 | -$70,453 | -$94,779 | -$59,832 |
| Capital Expenditures | -$554 | -$1,871 | -$9,601 | -$5,157 |
| Free Cash Flow | -$45,318 | -$72,324 | -$104,380 | -$64,989 |